Martin, S. D., Thornton, S., Chow, C., Milne, K., Barros, J. S. d., Morris, K. A., . . . Zhang, A. W. (2025). Activated immune infiltrates expand opportunities for targeted therapy in p53‐abnormal endometrial carcinoma. Wiley. https://doi.org/10.1002/path.6429
Chicago Style (17th ed.) CitationMartin, Spencer D., et al. Activated Immune Infiltrates Expand Opportunities for Targeted Therapy in P53‐abnormal Endometrial Carcinoma. Wiley, 2025. https://doi.org/10.1002/path.6429.
MLA (9th ed.) CitationMartin, Spencer D., et al. Activated Immune Infiltrates Expand Opportunities for Targeted Therapy in P53‐abnormal Endometrial Carcinoma. Wiley, 2025. https://doi.org/10.1002/path.6429.
Warning: These citations may not always be 100% accurate.